Recent advances in live cell imaging of hepatoma cells

BMC Cell Biology

Volumn 15, Issue 1, 2014, Pages

  Salipalli, Sandeep ^a   Singh, Prafull K ^a   Borlak, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bioluminescence; Fluorescence; Green Fluorescent Protein; Lipid droplet; Live cell imaging; Proximity ligation assay

Indexed keywords

ACTIN; BIOLOGICAL MARKER; BLUE FLUORESCENT PROTEIN; CHLOROQUINE; CYAN FLUORESCENT PROTEIN; FAT DROPLET; FLUORESCENT DYE; FLUOROGEN ACTIVATING PROTEIN; GREEN FLUORESCENT PROTEIN; HISTONE; LIPID; LIPOSOME; PEPTIDES AND PROTEINS; POVIDONE; RED FLUORESCENT PROTEIN; TUBULIN; UNCLASSIFIED DRUG; VIRUS VECTOR; YELLOW FLUORESCENT PROTEIN; LUMINESCENT AGENT; PHOTOPROTEIN;

BIOASSAY; BIOLUMINESCENCE; CELL LINE; CELL METABOLISM; CELL NUCLEUS; CELL ORGANELLE; CYTOLOGY; ENDOSOME; FLUORESCENCE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; GOLGI COMPLEX; HEPATIC CELL LINE; HEPATOMA CELL; HUMAN; LIPID METABOLISM; LIPOFECTION; LIVE CELL IMAGING; LIVER CELL; MICROSCOPY; MITOCHONDRION; NONHUMAN; PEROXISOME; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROXIMITY LIGATION ASSAY; REVIEW; ANIMAL; BLEACHING; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; PROCEDURES;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIVER; LIVER NEOPLASMS; LUMINESCENT AGENTS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; OPTICAL IMAGING; PHOTOBLEACHING;

EID: 84903806711     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-15-26     Document Type: Review

References (115)

1. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci U S A 2002, 99(1):377-382.
2. Nakajima Y, Yamazaki T, Nishii S, Noguchi T, Hoshino H, Niwa K, Viviani VR, Ohmiya Y. Enhanced beetle luciferase for high-resolution bioluminescence imaging. PLoS One 2010, 5(4):e10011.
3. Shimomura O. The discovery of aequorin and green fluorescent protein. J Microsc 2005, 217(1):1-15.
4. Shimomura O. Discovery of green fluorescent protein. Methods Biochem Anal 2006, 47:1-13.
5. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012, 10(12):1342-1359.e2.
6. Oh JH, Sohn HY, Kim JM, Kim YS, Kim NS. Construction of multi-purpose vectors, pCNS and pCNS-D2, are suitable for collection and functional study of large-scale cDNAs. Plasmid 2004, 51(3):217-226.
7. Harada N, Fujimoto E, Okuyama M, Sakaue H, Nakaya Y. Identification and functional characterization of human glycerol-3-phosphate acyltransferase 1 gene promoters. Biochem Biophys Res Commun 2012, 423(1):128-133.
8. Ormo M, Cubitt AB, Kallio K, Gross LA, Tsien RY, Remington SJ. Crystal structure of the Aequorea victoria green fluorescent protein. Science 1996, 273(5280):1392-1395.
9. Heim R, Cubitt AB, Tsien RY. Improved green fluorescence. Nature 1995, 373(6516):663-664.
10. Wang Y, Shyy JY, Chien S. Fluorescence proteins, live-cell imaging, and mechanobiology: seeing is believing. Annu Rev Biomed Eng 2008, 10:1-38.
11. Tsien RY. The green fluorescent protein. Annu Rev Biochem 1998, 67:509-544.
12. Delagrave S, Hawtin RE, Silva CM, Yang MM, Youvan DC. Red-shifted excitation mutants of the green fluorescent protein. Biotechnology (N Y) 1995, 13(2):151-154.
13. Zacharias DA, Violin JD, Newton AC, Tsien RY. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 2002, 296(5569):913-916.
14. Lippincott-Schwartz J, Roberts TH, Hirschberg K. Secretory protein trafficking and organelle dynamics in living cells. Annu Rev Cell Dev Biol 2000, 16:557-589.
15. Hirschberg K, Miller CM, Ellenberg J, Presley JF, Siggia ED, Phair RD, Lippincott-Schwartz J. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol 1998, 143(6):1485-1503.
16. Patterson GH, Knobel SM, Sharif WD, Kain SR, Piston DW. Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy. Biophys J 1997, 73(5):2782-2790.
17. Heim R, Prasher DC, Tsien RY. Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci U S A 1994, 91(26):12501-12504.
18. Ehrig T, O'Kane DJ, Prendergast FG. Green-fluorescent protein mutants with altered fluorescence excitation spectra. FEBS Lett 1995, 367(2):163-166.
19. Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996, 173(1 Spec No):33-38.
20. Zapata-Hommer O, Griesbeck O. Efficiently folding and circularly permuted variants of the Sapphire mutant of GFP. BMC Biotechnol 2003, 3:5.
21. Cubitt AB, Woollenweber LA, Heim R. Understanding structure-function relationships in the Aequorea victoria green fluorescent protein. Methods Cell Biol 1999, 58:19-30.
22. Pédelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS. Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol 2006, 24(1):79-88.
23. Ai HW, Shaner NC, Cheng Z, Tsien RY, Campbell RE. Exploration of new chromophore structures leads to the identification of improved blue fluorescent proteins. Biochemistry 2007, 46(20):5904-5910.
24. Mena MA, Treynor TP, Mayo SL, Daugherty PS. Blue fluorescent proteins with enhanced brightness and photostability from a structurally targeted library. Nat Biotechnol 2006, 24(12):1569-1571.
25. Tomosugi W, Matsuda T, Tani T, Nemoto T, Kotera I, Saito K, Horikawa K, Nagai T. An ultramarine fluorescent protein with increased photostability and pH insensitivity. Nat Methods 2009, 6(5):351-353.
26. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY. Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 1995, 20(11):448-455.
27. Rizzo MA, Springer GH, Granada B, Piston DW. An improved cyan fluorescent protein variant useful for FRET. Nat Biotechnol 2004, 22(4):445-449.
28. Miyawaki A, Griesbeck O, Heim R, Tsien RY. Dynamic and quantitative Ca2+ measurements using improved cameleons. Proc Natl Acad Sci U S A 1999, 96(5):2135-2140.
29. Griesbeck O, Baird GS, Campbell RE, Zacharias DA, Tsien RY. Reducing the environmental sensitivity of yellow fluorescent protein: mechanism and applications. J Biol Chem 2001, 276(31):29188-29194.
30. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 2002, 20(1):87-90.
31. Rizzuto R, Brini M, De Giorgi F, Rossi R, Heim R, Tsien RY, Pozzan T. Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo. Curr Biol 1996, 6(2):183-188.
32. Heim R, Tsien RY. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 1996, 6(2):178-182.
33. Ellenberg J, Lippincott-Schwartz J, Presley JF. Two-color green fluorescent protein time-lapse imaging. BioTechniques 1998, 25(5):838-842. 844-6.
34. Yang TT, Sinai P, Green G, Kitts PA, Chen YT, Lybarger L, Chervenak R, Patterson GH, Piston DW, Kain SR. Improved fluorescence and dual color detection with enhanced blue and green variants of the green fluorescent protein. J Biol Chem 1998, 273(14):8212-8216.
35. Shaner NC, Patterson GH, Davidson MW. Advances in fluorescent protein technology. J Cell Sci 2007, 120:4247-4260.
36. Subach OM, Gundorov IS, Yoshimura M, Subach FV, Zhang J, Gruenwald D, Souslova EA, Chudakov DM, Verkhusha VV. Conversion of red fluorescent protein into a bright blue probe. Chem Biol 2008, 15(10):1116-1124.
37. Subach OM, Cranfill PJ, Davidson MW, Verkhusha VV. An enhanced monomeric blue fluorescent protein with the high chemical stability of the chromophore. PLoS One 2011, 6(12):e28674.
38. Nguyen AW, Daugherty PS. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat Biotechnol 2005, 23(3):355-360.
39. Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, Markelov ML, Lukyanov SA. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotechnol 1999, 17(10):969-973.
40. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, Tsien RY. A monomeric red fluorescent protein. Proc Natl Acad Sci U S A 2002, 99(12):7877-7882.
41. Hu YL, Chien S. Dynamic motion of paxillin on actin filaments in living endothelial cells. Biochem Biophys Res Commun 2007, 357(4):871-876.
42. Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nat Methods 2005, 2(12):905-909.
43. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 2004, 22(12):1567-1572.
44. Merzlyak EM, Goedhart J, Shcherbo D, Bulina ME, Shcheglov AS, Fradkov AF, Gaintzeva A, Lukyanov KA, Lukyanov S, Gadella TW, Chudakov DM. Bright monomeric red fluorescent protein with an extended fluorescence lifetime. Nat Methods 2007, 4(7):555-557.
45. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994, 263(5148):802-805.
46. Inouye S, Tsuji FI. Aequorea green fluorescent protein: expression of the gene and fluorescence characteristics of the recombinant protein. FEBS Lett 1994, 341(2-3):277-280.
47. Bestvater F, Spiess E, Stobrawa G, Hacker M, Feurer T, Porwol T, Berchner-Pfannschmidt U, Wotzlaw C, Acker H. Two-photon fluorescence absorption and emission spectra of dyes relevant for cell imaging. J Microsc 2002, 208(Pt 2):108-115.
48. Joanny F, Held J, Mordmuller B. In vitro activity of fluorescent dyes against asexual blood stages of Plasmodium falciparum. Antimicrob Agents Chemother 2012, 56(11):5982-5985.
49. Iwaki T, Torigoe C, Noji M, Nakanishi M. Antibodies for fluorescent molecular rotors. Biochemistry 1993, 32(29):7589-7592.
50. Irtegun S, Ramdzan YM, Mulhern TD, Hatters DM. ReAsH/FlAsH labeling and image analysis of tetracysteine sensor proteins in cells. J Vis Exp 2011, 31(54):2-7.
51. Griffin BA, Adams SR, Tsien RY. Specific covalent labeling of recombinant protein molecules inside live cells. Science 1998, 281(5374):269-272.
52. Miyawaki A, Llopis J, Heim R, McCaffery JM, Adams JA, Ikura M, Tsien RY. Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. Nature 1997, 388(6645):882-887.
53. Adams SR, Campbell RE, Gross LA, Martin BR, Walkup GK, Yao Y, Llopis J, Tsien RY. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc 2002, 124(21):6063-6076.
54. Szent-Gyorgyi C, Schmidt BF, Creeger Y, Fisher GW, Zakel KL, Adler S, Fitzpatrick JA, Woolford CA, Yan Q, Vasilev KV, Berget PB, Bruchez MP, Jarvik JW, Waggoner A. Fluorogen-activating single-chain antibodies for imaging cell surface proteins. Nat Biotechnol 2008, 26(2):235-240.
55. Nygren J, Svanvik N, Kubista M. The interactions between the fluorescent dye thiazole orange and DNA. Biopolymers 1998, 46(1):39-51.
56. Babendure JR, Adams SR, Tsien RY. Aptamers switch on fluorescence of triphenylmethane dyes. J Am Chem Soc 2003, 125(48):14716-14717.
57. Holleran J, Brown D, Fuhrman MH, Adler SA, Fisher GW, Jarvik JW. Fluorogen-activating proteins as biosensors of cell-surface proteins in living cells. Cytometry A 2010, 77(8):776-782.
58. Lucifora J, Durantel D, Belloni L, Barraud L, Villet S, Vincent IE, Margeridon-Thermet S, Hantz O, Kay A, Levrero M, Zoulim F. Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector. J Gen Virol 2008, 89(Pt 8):1819-1828.
59. Kramer MG, Barajas M, Razquin N, Berraondo P, Rodrigo M, Wu C, Qian C, Fortes P, Prieto J. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol Ther 2003, 7(3):375-385.
60. Rotondaro L, Mele A, Rovera G. Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3'-untranslated sequences. Gene 1996, 168(2):195-198.
61. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334(6180):320-325.
62. Yang Y, Tan WJ. Progress on development and research of coronavirus based vector. Bing Du Xue Bao 2012, 28(3):297-302.
63. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988, 62(8):2636-2643.
64. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982, 1(7):841-845.
65. Gurdon JB. Gene expression in early animal development: the study of its control by the microinjection of amphibian eggs. Harvey Lect 1973, 69:49-69.
66. Kawasaki Y, Matsumoto S, Nagamine T. Analysis of baculovirus IE1 in living cells: dynamics and spatial relationships to viral structural proteins. J Gen Virol 2004, 85(Pt 12):3575-3583.
67. Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 2001, 8(11):846-854.
68. Ge J, Tang X, Gao D, Song S, Lu S, Lou Z, Ping W. Construction of BV-T7 hybrid expression system based on baculovirus to express target gene eGFP in mammalian and chicken cells. Wei Sheng Wu Xue Bao 2012, 52(3):318-325.
69. Lo WH, Chen CY, Yeh CN, Lin CY, Hu YC. Rapid baculovirus titration based on regulatable green fluorescent protein expression in mammalian cells. Enzyme Microb Technol 2011, 48(1):13-18.
70. Llosa M, Schröder G, Dehio C. New perspectives into bacterial DNA transfer to human cells. Trends Microbiol 2012, 20(8):355-359.
71. Akyüz MD, Balci Hayta B, Di{dotless}nçer PR. An efficient method for stable transfection of mouse myogenic C2C12 cell line using a nonviral transfection approach. Turk J Med Sci 2011, 41(5):821-825.
72. Hahnenberger K, Chan S. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer. Agilent Tecnologies 2001, Publication Number 5988-4320EN. [http://www.chem.agilent.com/library/applications/59884320_025445.pdf].
73. Legendre JY, Szoka FC. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm Res 1992, 9(10):1235-1242.
74. Gopal V, Xavier J, Kamal MZ, Govindarajan S, Takafuji M, Soga S, Ueno T, Ihara H, Rao NM. Synthesis and transfection efficiency of cationic oligopeptide lipids: role of linker. Bioconjug Chem 2011, 22(11):2244-2254.
75. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009, 109(2):259-302.
76. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007, 9(3):316-323.
77. Oberbek A, Matasci M, Hacker DL, Wurm FM. Generation of stable, high-producing CHO cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture. Biotechnol Bioeng 2011, 108(3):600-610.
78. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003, 77(16):8957-8961.
79. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Commentary: lysosomotropic agents. Biochem Pharmacol 1974, 23(18):2495-2531.
80. Luthman H, Magnusson G. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res 1983, 11(5):1295-1308.
81. Lucas P, Pouton CW, Moss SH. Influence of formulation factors on gene transfer mediated by cationic polypeptides. Proc Int Symp Control Rel Bioact Mater 1995, 22:468-469.
82. Walsh SM, Flotte TR, Beck S, Allen S, Guggino WB, August T, Leong KW. Delivery of cftr gene to rabbit airways by gelatin-DNA microspheres. Proc Controlled Rel Soc 1996, 23:73-74.
83. Levy MY, Meyer KB, Barron L, Szoka FC. Mechanism of gene uptake and expression in adult mouse skeletal muscle. Pharm Res 1994, 11:317-321.
84. Ciftci K, Levy RJ. Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int J Pharm 2001, 218(1-2):81-92.
85. Wildenthal K, Dees JH, Buja LM. Cardiac lysosomal derangements in mouse heart after long term exposure to non metabolizable sugars. Circ Res 1977, 40:26-35.
86. Kato T, Okada S, Yutaka T, Yabuuchi H. The effects of sucrose loading on lysosomal hydrolases. Mol Cell Biochem 1984, 60(1):83-98.
87. Ose L, Ose T, Reinertsen R, Berg T. Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells. Exp Cell Res 1980, 126(1):109-119.
88. Needham CJ, Williams AK, Chew SA, Kasper FK, Mikos AG. Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid. Biomacromolecules 2012, 13(5):1429-1437.
89. Dey D, Inayathullah M, Lee AS, LeMieux MC, Zhang X, Wu Y, Nag D, De Almeida PE, Han L, Rajadas J, Wu JC. Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybrid. Biomaterials 2011, 32(20):4647-4658.
90. Dai J, Zou S, Pei Y, Cheng D, Ai H, Shuai X. Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery. Biomaterials 2011, 32(6):1694-1705.
91. Ahmed M, Narain R. Cell line dependent uptake and transfection efficiencies of PEI-anionic glycopolymer systems. Biomaterials 2013, 34(17):4368-4376.
92. Duan SY, Ge XM, Lu N, Wu F, Yuan W, Jin T. Synthetic polyspermine imidazole-4, 5-amide as an efficient and cytotoxicity-free gene delivery system. Int J Nanomed 2012, 7:3813-3822.
93. Targett-Adams P, Chambers D, Gledhill S, Hope RG, Coy JF, Girod A, McLauchlan J. Live cell analysis and targeting of the lipid droplet-binding adipocyte differentiation-related protein. J Biol Chem 2003, 278(18):15998-16007.
94. Tolosa L, Donato MT, Perez-Cataldo G, Castell JV, Gomez-Lechon MJ. Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment. Toxicol In Vitro 2012, 26(8):1272-1277.
95. Tolosa L, Gomez-Lechon MJ, Perez-Cataldo G, Castell JV, Donato MT. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved. Arch Toxicol 2013, 87(6):1115-1127.
96. Wilson JM, Jefferson DM, Chowdhury JR, Novikoff PM, Johnston DE, Mulligan RC. Retrovirus-mediated transduction of adult hepatocytes. Proc Natl Acad Sci U S A 1988, 85(9):3014-3018.
97. Bosch A, McCray PB, Walters KS, Bodner M, Jolly DJ, van Es HH, Nakamura T, Matsumoto K, Davidson BL. Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liver. Hum Gene Ther 1998, 9(12):1747-1754.
98. Patijn GA, Lieber A, Schowalter DB, Schwall R, Kay MA. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 1998, 28(3):707-716.
99. Forbes SJ, Themis M, Alison MR, Sarosi I, Coutelle C, Hodgson HJ. Synergistic growth factors enhance rat liver proliferation and enable retroviral gene transfer via a peripheral vein. Gastroenterology 2000, 118(3):591-598.
100. Buchschacher GL, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000, 95(8):2499-2504.
101. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000, 7(1):20-23.
102. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998, 9(5):457-463.
103. Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma. Cell Biochem Biophys 2012, 62(1):237-244.
104. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 2004, 78(3):1448-1455.
105. Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 2006, 7(5):373-378.
106. Yang HJ, Hsu CL, Yang JY, Yang WY. Monodansylpentane as a blue-fluorescent lipid-droplet marker for multi-color live-cell imaging. PLoS One 2012, 7(3):e32693.
107. Niemann A, Baltes J, Elsasser HP. Fluorescence properties and staining behavior of monodansylpentane, a structural homologue of the lysosomotropic agent monodansylcadaverine. J Histochem Cytochem 2001, 49(2):177-185.
108. Jares-Erijman EA, Jovin TM. FRET imaging. Nat Biotechnol 2003, 21(11):1387-1395.
109. Sturmey RG, O'Toole PJ, Leese HJ. Fluorescence resonance energy transfer analysis of mitochondrial:lipid association in the porcine oocyte. Reproduction 2006, 132(6):829-837.
110. McIntosh AL, Senthivinayagam S, Moon KC, Gupta S, Lwande JS, Murphy CC, Storey SM, Atshaves BP. Direct interaction of Plin2 with lipids on the surface of lipid droplets: a live cell FRET analysis. Am J Physiol Cell Physiol 2012, 303(7):C728-C742.
111. Bae JH, Rubini M, Jung G, Wiegand G, Seifert MH, Azim MK, Kim JS, Zumbusch A, Holak TA, Moroder L, Huber R, Budisa N. Expansion of the genetic code enables design of a novel "gold" class of green fluorescent proteins. J Mol Biol 2003, 328(5):1071-1081.
112. Heid HW, Moll R, Schwetlick I, Rackwitz HR, Keenan TW. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res 1998, 294(2):309-321.
113. Blouin CM, Le Lay S, Eberl A, Kofeler HC, Guerrera IC, Klein C, Le Liepvre X, Lasnier F, Bourron O, Gautier JF, Ferre P, Hajduch E, Dugail I. Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects. J Lipid Res 2010, 51(5):945-956.
114. Weibrecht I, Leuchowius KJ, Clausson CM, Conze T, Jarvius M, Howell WM, Kamali-Moghaddam M, Söderberg O. Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev Proteomics 2010, 7(3):401-409.
115. Zirath H, Frenzel A, Oliynyk G, Segerström L, Westermark UK, Larsson K, Munksgaard Persson M, Hultenby K, Lehtiö J, Einvik C, Påhlman S, Kogner P, Jakobsson PJ, Henriksson MA. MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells. Proc Natl Acad Sci U S A 2013, 110(25):10258-10263.